“
In 2009, a start-up Danish drug company called Santaris announced successful use of LNA’s remarkable properties against the hepatitis C virus. The LNA in the medication bonds with microRNA in the HepC virus, preventing the virus from duplicating. Essentially, the LNA “locks” the gene in the off position.
”
”
Thomas Horn (Pandemonium's Engine: How the End of the Church Age, the Rise of Transhumanism, and the Coming of the bermensch (Overman) Herald Satans Imminent and Final Assault on the Creation of God)